Novartis Ag (NVSEF) Equity Ratio (2015 - 2025)

Novartis Ag (NVSEF) has 10 years of Equity Ratio data on file, last reported at 0.42 in Q4 2025.

• Quarterly Equity Ratio fell 3.66% year-over-year to 0.42 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.42 (down 3.66% YoY) and the FY2025 annual result came in at 0.42, down 3.66% from the prior year.
• Equity Ratio slipped to 0.42 in Q4 2025 per NVSEF's latest filing, from 0.43 in the prior quarter.
• The five-year high for Equity Ratio was 0.51 in Q4 2021, with the low at 0.42 in Q4 2025.
• Average Equity Ratio over 5 years is 0.47, with a median of 0.47 recorded in 2023.
• Year-over-year, Equity Ratio surged 4733.89% in 2021 and declined 7.74% in 2024.
• Novartis Ag's Equity Ratio stood at 0.51 in 2021, then declined by 1.69% to 0.51 in 2022, then fell by 7.55% to 0.47 in 2023, then decreased by 7.74% to 0.43 in 2024, then declined by 3.66% to 0.42 in 2025.
• Business Quant data shows NVSEF's Equity Ratio at 0.42 in Q4 2025, 0.43 in Q4 2024, and 0.47 in Q4 2023.